ANALYSE TRAITEMENTS PARISIENS : revenue, balance sheet and financial ratios

ANALYSE TRAITEMENTS PARISIENS is a French company founded 40 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in PARIS (75009), this company of category PME shows in 2024 a revenue of 90 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ANALYSE TRAITEMENTS PARISIENS (SIREN 334925781)
Indicator 2024 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 90 000 € 2 311 651 € 100 000 € 1 589 213 € 321 000 € 297 850 € 119 027 € 1 083 208 € 560 000 €
Net income -1 854 250 € -232 233 € 85 703 € 41 432 € -9 238 € 11 895 € -36 320 € 230 282 € -12 337 €
EBITDA 30 205 € -102 627 € -1 988 € -899 € -21 215 € -8 205 € -60 710 € -2 512 € -76 583 €
Net margin -2060.3% -10.0% 85.7% 2.6% -2.9% 4.0% -30.5% 21.3% -2.2%

Revenue and income statement

In 2024, ANALYSE TRAITEMENTS PARISIENS achieves revenue of 90 k€. Revenue is declining over the period 2015-2024 (CAGR: -18.4%). Significant drop of -96% vs 2022. After deducting consumption (5 €), gross margin stands at 90 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 30 k€, representing 33.6% of revenue. Positive scissor effect: EBITDA margin improves by +38.0 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Net income is negative at -1.9 M€ (-2060.3% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

90 000 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

89 995 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

30 205 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

27 801 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-1 854 250 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

33.6%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 41%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

41.273%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

66.353%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-2057.568%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-7.103

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

19.3%

Solvency indicators evolution
ANALYSE TRAITEMENTS PARISIENS

Sector positioning

Debt ratio
41.27 2024
2021
2022
2024
Q1: 0.01
Med: 13.69
Q3: 116.56
Average +32 pts over 3 years

In 2024, the debt ratio of ANALYSE TRAITEMENTS PARIS... (41.27) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
66.35% 2024
2021
2022
2024
Q1: 13.95%
Med: 55.8%
Q3: 90.35%
Good -17 pts over 3 years

In 2024, the financial autonomy of ANALYSE TRAITEMENTS PARIS... (66.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
-7.1 years 2024
2021
2022
2024
Q1: 0.0 years
Med: 0.15 years
Q3: 4.69 years
Excellent -17 pts over 3 years

In 2024, the repayment capacity of ANALYSE TRAITEMENTS PARIS... (-7.10) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 313.25. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 9337.0x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

313.25

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

9337.034

Liquidity indicators evolution
ANALYSE TRAITEMENTS PARISIENS

Sector positioning

Liquidity ratio
313.25 2024
2021
2022
2024
Q1: 132.35
Med: 897.73
Q3: 5412.13
Average -44 pts over 3 years

In 2024, the liquidity ratio of ANALYSE TRAITEMENTS PARIS... (313.25) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
9337.03x 2024
2021
2022
2024
Q1: -144.56x
Med: -8.16x
Q3: 0.0x
Excellent +50 pts over 3 years

In 2024, the interest coverage of ANALYSE TRAITEMENTS PARIS... (9337.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 35 days. Excellent situation: suppliers finance 35 days of the operating cycle (retail model). Inventory turnover is 27731 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 16411 days of revenue, i.e. 4.1 M€ to permanently finance. Notable WCR improvement over the period (-59%), freeing up cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

4 102 842 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

35 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

27731 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

16411 j

WCR and payment terms evolution
ANALYSE TRAITEMENTS PARISIENS

Positioning of ANALYSE TRAITEMENTS PARISIENS in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (26 transactions). This range of 115 204€ to 250 530€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
115k€ 195k€ 250k€
195 711 € Range: 115 204€ - 250 530€
NAF 5 année 2024

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 26 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare ANALYSE TRAITEMENTS PARISIENS with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about ANALYSE TRAITEMENTS PARISIENS

What is the revenue of ANALYSE TRAITEMENTS PARISIENS ?

The revenue of ANALYSE TRAITEMENTS PARISIENS in 2024 is 90 k€.

Is ANALYSE TRAITEMENTS PARISIENS profitable?

ANALYSE TRAITEMENTS PARISIENS recorded a net loss in 2024.

Where is the headquarters of ANALYSE TRAITEMENTS PARISIENS ?

The headquarters of ANALYSE TRAITEMENTS PARISIENS is located in PARIS (75009), in the department Paris.

Where to find the tax return of ANALYSE TRAITEMENTS PARISIENS ?

The tax return of ANALYSE TRAITEMENTS PARISIENS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ANALYSE TRAITEMENTS PARISIENS operate?

ANALYSE TRAITEMENTS PARISIENS operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.